Betulinic acid ameliorates experimental diabetic-induced renal inflammation and fibrosis via inhibiting the activation of NF-κB signaling pathway

Molecular and Cellular Endocrinology

Volumn 434, Issue , 2016, Pages 135-143

  Wang, Shaogui ^a   Yang, Zhiying ^a   Xiong, Fengxiao ^a   Chen, Cheng ^a   Chao, Xiaojuan ^a   Huang, Junying ^a   Huang, Heqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Betulinic acid; Diabetic nephropathy; Fibronectin; NF B

Indexed keywords

BETA ARRESTIN 2; BETULIC ACID; FIBRONECTIN; GLUCOSE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; I KAPPA B; NONSTEROID ANTIINFLAMMATORY AGENT; STREPTOZOCIN; TRITERPENE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA BINDING; EXPERIMENTAL DIABETES MELLITUS; GENETIC TRANSCRIPTION; KIDNEY FIBROSIS; MALE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CELL CULTURE; CHEMICALLY INDUCED; COMPLICATION; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; KIDNEY; METABOLISM;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-ARRESTIN 2; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION REGULATION; GLUCOSE; I-KAPPA B PROTEINS; KIDNEY; MESANGIAL CELLS; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; STREPTOZOCIN; TRITERPENES;

EID: 84976892450     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2016.06.019     Document Type: Article

References (45)

1. Chen, S., Khan, Z.A., Cukiernik, M., Chakrabarti, S., Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am. J. Physiol. Endocrinol. Metab. 284:6 (2003), E1089–E1097.
2. DeWire, S.M., Ahn, S., Lefkowitz, R.J., Shenoy, S.K., Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69 (2007), 483–510.
3. Eksioglu-Demiralp, E., Kardas, E.R., Ozgul, S., Yagci, T., Bilgin, H., Sehirli, O., Ercan, F., Sener, G., Betulinic acid protects against ischemia/reperfusion-induced renal damage and inhibits leukocyte apoptosis. Phytother. Res. 24:3 (2010), 325–332.
4. Fujioka, T., Kashiwada, Y., Kilkuskie, R.E., Cosentino, L.M., Ballas, L.M., Jiang, J.B., Janzen, W.P., Chen, I.S., Lee, K.H., Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids. J. Nat. Prod. 57:2 (1994), 243–247.
5. Gao, H., Sun, Y., Wu, Y., Luan, B., Wang, Y., Qu, B., Pei, G., Identification of beta-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-kappaB pathways. Mol. Cell 14:3 (2004), 303–317.
6. Genet, C., Strehle, A., Schmidt, C., Boudjelal, G., Lobstein, A., Schoonjans, K., Souchet, M., Auwerx, J., Saladin, R., Wagner, A., Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes. J. Med. Chem. 53:1 (2010), 178–190.
7. Gilmore, T.D., Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25:51 (2006), 6680–6684.
8. Harper, P.A., Robinson, J.M., Hoover, R.L., Wright, T.C., Karnovsky, M.J., Improved methods for culturing rat glomerular cells. Kidney Int. 26:6 (1984), 875–880.
9. Ichinose, K., Kawasaki, E., Eguchi, K., Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy. Am. J. Nephrol. 27:6 (2007), 554–564.
10. Innocente, A.M., Silva, G.N., Cruz, L.N., Moraes, M.S., Nakabashi, M., Sonnet, P., Gosmann, G., Garcia, C.R., Gnoatto, S.C., Synthesis and antiplasmodial activity of betulinic acid and ursolic acid analogues. Molecules 17:10 (2012), 12003–12014.
11. Jain, M., Kapadia, R., Jadeja, R.N., Thounaojam, M.C., Devkar, R.V., Mishra, S.H., Hepatoprotective potential of Tecomella undulata stem bark is partially due to the presence of betulinic acid. J. Ethnopharmacol. 143:1 (2012), 194–200.
12. Lan, T., Wu, T., Chen, C., Chen, X., Hao, J., Huang, J., Wang, L., Huang, H., Berberine attenuates high glucose-induced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-kappaB/AP-1 pathways. Mol. Cell. Endocrinol. 384:1–2 (2014), 109–116.
13. Lefkowitz, R.J., Shenoy, S.K., Transduction of receptor signals by beta-arrestins. Science 308:5721 (2005), 512–517.
14. Lefkowitz, R.J., Whalen, E.J., beta-arrestins: traffic cops of cell signaling. Curr. Opin. Cell Biol. 16:2 (2004), 162–168.
15. Lewis, E.J., Hunsicker, L.G., Bain, R.P., Rohde, R.D., The Collaborative Study Group, The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N. Engl. J. Med. 329:20 (1993), 1456–1462.
16. Lim, A., Diabetic nephropathy - complications and treatment. Int. J. Nephrol. Renovasc. Dis. 7 (2014), 361–381.
17. Luan, B., Zhang, Z., Wu, Y., Kang, J., Pei, G., Beta-arrestin2 functions as a phosphorylation-regulated suppressor of UV-induced NF-kappaB activation. EMBO J. 24:24 (2005), 4237–4246.
18. Luttrell, L.M., Lefkowitz, R.J., The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115:Pt 3 (2002), 455–465.
19. Ma, L., Pei, G., Beta-arrestin signaling and regulation of transcription. J. Cell Sci. 120:Pt 2 (2007), 213–218.
20. Mason, R.M., Wahab, N.A., Extracellular matrix metabolism in diabetic nephropathy. J. Am. Soc. Nephrol. 14:5 (2003), 1358–1373.
21. Mene, P., Stoppacciaro, A., Isolation and propagation of glomerular mesangial cells. Methods Mol. Biol. 466 (2009), 3–17.
22. Mezzano, S., Aros, C., Droguett, A., Burgos, M.E., Ardiles, L., Flores, C., Schneider, H., Ruiz-Ortega, M., Egido, J., NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol. Dial. Transpl. 19:10 (2004), 2505–2512.
23. Nagarajan, R.P., Chen, F., Li, W., Vig, E., Harrington, M.A., Nakshatri, H., Chen, Y., Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB. Biochem. J. 348:Pt 3 (2000), 591–596.
24. Nam, J.S., Cho, M.H., Lee, G.T., Park, J.S., Ahn, C.W., Cha, B.S., Lim, S.K., Kim, K.R., Ha, H.J., Lee, H.C., The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res. Clin. Pract. 81:1 (2008), 25–32.
25. Navarro-Gonzalez, J.F., Mora-Fernandez, C., The role of inflammatory cytokines in diabetic nephropathy. J. Am. Soc. Nephrol. 19:3 (2008), 433–442.
26. Navarro-Gonzalez, J.F., Mora-Fernandez, C., Muros de Fuentes, M., Garcia-Perez, J., Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat. Rev. Nephrol. 7:6 (2011), 327–340.
27. Navarro, J.F., Mora, C., Role of inflammation in diabetic complications. Nephrol. Dial. Transpl. 20:12 (2005), 2601–2604.
28. Pahl, H.L., Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:49 (1999), 6853–6866.
29. Park, C.W., Kim, J.H., Lee, J.H., Kim, Y.S., Ahn, H.J., Shin, Y.S., Kim, S.Y., Choi, E.J., Chang, Y.S., Bang, B.K., High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia 43:12 (2000), 1544–1553.
30. Pisha, E., Chai, H., Lee, I.S., Chagwedera, T.E., Farnsworth, N.R., Cordell, G.A., Beecher, C.W., Fong, H.H., Kinghorn, A.D., Brown, D.M., et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1:10 (1995), 1046–1051.
31. Sanchez, A.P., Sharma, K., Transcription factors in the pathogenesis of diabetic nephropathy. Expert Rev. Mol. Med., 11, 2009, e13.
32. Schlondorff, D., The glomerular mesangial cell: an expanding role for a specialized pericyte. FASEB J. 1:4 (1987), 272–281.
33. Schlondorff, D., Banas, B., The mesangial cell revisited: no cell is an island. J. Am. Soc. Nephrol. 20:6 (2009), 1179–1187.
34. Schmid, H., Boucherot, A., Yasuda, Y., Henger, A., Brunner, B., Eichinger, F., Nitsche, A., Kiss, E., Bleich, M., Grone, H.J., Nelson, P.J., Schlondorff, D., Cohen, C.D., Kretzler, M., D. N. A. B. C. European Renal c, Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes 55:11 (2006), 2993–3003.
35. Shenoy, S.K., Lefkowitz, R.J., Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem. J. 375:Pt 3 (2003), 503–515.
36. Stockand, J.D., Sansom, S.C., Glomerular mesangial cells: electrophysiology and regulation of contraction. Physiol. Rev. 78:3 (1998), 723–744.
37. Tak, P.P., Firestein, G.S., NF-kappaB: a key role in inflammatory diseases. J. Clin. Investig. 107:1 (2001), 7–11.
38. Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., Pellicciari, R., Auwerx, J., Schoonjans, K., TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 10:3 (2009), 167–177.
39. Wang, Y.D., Chen, W.D., Yu, D., Forman, B.M., Huang, W., The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice. Hepatology 54:4 (2011), 1421–1432.
40. Watanabe, M., Houten, S.M., Mataki, C., Christoffolete, M.A., Kim, B.W., Sato, H., Messaddeq, N., Harney, J.W., Ezaki, O., Kodama, T., Schoonjans, K., Bianco, A.C., Auwerx, J., Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439:7075 (2006), 484–489.
41. Witherow, D.S., Garrison, T.R., Miller, W.E., Lefkowitz, R.J., beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha. Proc. Natl. Acad. Sci. U. S. A. 101:23 (2004), 8603–8607.
42. Wolf, G., Ziyadeh, F.N., Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol. 106:2 (2007), p26–31.
43. Xie, X., Chang, X., Chen, L., Huang, K., Huang, J., Wang, S., Shen, X., Liu, P., Huang, H., Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling. Mol. Cell. Endocrinol. 381:1–2 (2013), 56–65.
44. Xie, X., Peng, J., Chang, X., Huang, K., Huang, J., Wang, S., Shen, X., Liu, P., Huang, H., Activation of RhoA/ROCK regulates NF-kappaB signaling pathway in experimental diabetic nephropathy. Mol. Cell. Endocrinol. 369:1–2 (2013), 86–97.
45. Yogeeswari, P., Sriram, D., Betulinic acid and its derivatives: a review on their biological properties. Curr. Med. Chem. 12:6 (2005), 657–666.